Tag Archives: CS

Spinoff Odds & Ends: New Activist At Shire $SHPG, RBR Raising Money To Fight $CS

By |
2 Comments

In this edition, we provide a few updates to some of our recent articles focusing on activist activities: 1) Sachem Head vs. Shire Pharmaceuticals (SHPG) Shire Pharmaceuticals announced this summer that it was considering its ‘strategic options’, including a potential spinoff, for its neuroscience division in order to better focus on its rare diseases business. Unfortunately, the company’s stock has… Read More »

Credit Suisse Attracts A Pesky Activist Who Wants To Make Swiss Cheese

By |
5 Comments

Tidjane Thiam’s tenure at the top of Credit Suisse (CS) has hardly been a picnic. Big lawsuits, struggling business units and a difficult overhaul has left the stock well below where he inherited it despite strong gains this year. The company is only two years into its grand ‘3 year plan’ which entails cutting costs, reducing the size… Read More »